NAVICAN - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87975639
Serial Number
87975639
Registration Number
5292993
Word Mark
NAVICAN
Status
700 - Registered
Status Date
2017-09-19
Filing Date
2016-06-30
Registration Number
5292993
Registration Date
2017-09-19
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2016-11-08
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
SHINER, MARK W
Statements
Goods and Services
Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; and promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving drug therapy
Goods and Services
Pharmaceutical benefit management services; insurance claims processing in the field of diagnostics and pharmaceutical claims; providing a database featuring information and statistics about patient reimbursement and insurance coverage for diagnostics and pharmaceuticals; and reimbursement payment processing in the field of diagnostics and pharmaceutical claims; and providing information in the field of financial support options and resources for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of diagnostics reimbursement for providers and patients; financial administration of diagnostics and pharmacy reimbursement programs and services
Goods and Services
Medical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals, clinical trials and genetics; technical consulting related to scientific and medical studies in the field of genetic diagnostic assay and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; basic and clinical research in the field of oncology, namely, researching genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals and clinical trials for personalized diagnosis, treatment and prevention of cancer; custom design and development of chemical reagants and multiplex sequencing assays for personalized diagnosis, treatment and prevention of cancer; providing an on-line computer database featuring medical and scientific research information in the field of oncology that allows for input and collection of scientific and research data and information relating to genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments for personalized diagnosis, treatment and prevention of cancer; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies for personalized diagnosis, treatment and prevention of cancer; providing a website featuring technology with a web-based interface where medical professionals can view genetic test results and interpretations of the results by scientists and medical professionals in the field of genomics, and select the appropriate treatment and order the necessary pharmaceutical products
Goods and Services
Dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy; physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of oncology; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; providing an online searchable database in the fields of oncolology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer
Classification Information
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2016-07-06
Primary Code
035
First Use Anywhere Date
2017-05-12
First Use In Commerce Date
2017-05-12
International Class
036 - Insurance; financial affairs; monetary affairs; real estate affairs. - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2016-07-06
Primary Code
036
First Use Anywhere Date
2017-05-12
First Use In Commerce Date
2017-05-12
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-07-06
Primary Code
042
First Use Anywhere Date
2017-05-12
First Use In Commerce Date
2017-05-12
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-07-06
Primary Code
044
First Use Anywhere Date
2017-05-12
First Use In Commerce Date
2017-05-12
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JOSHUA G. GIGGER
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Continuity Parent87090027
Trademark Events
Event DateEvent Description
2016-07-04NEW APPLICATION ENTERED IN TRAM
2016-07-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-07-14TEAS VOLUNTARY AMENDMENT RECEIVED
2016-07-14TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
2016-09-07ASSIGNED TO EXAMINER
2016-09-14EXAMINERS AMENDMENT -WRITTEN
2016-09-14EXAMINERS AMENDMENT E-MAILED
2016-09-14NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-09-14EXAMINER'S AMENDMENT ENTERED
2016-09-14APPROVED FOR PUB - PRINCIPAL REGISTER
2016-09-27ASSIGNED TO LIE
2016-10-04LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-10-19NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-11-08PUBLISHED FOR OPPOSITION
2016-11-08OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-01-03NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2017-06-30TEAS STATEMENT OF USE RECEIVED
2017-06-30TEAS REQUEST TO DIVIDE RECEIVED
2017-07-21CASE ASSIGNED TO INTENT TO USE PARALEGAL
2017-06-30DIVISIONAL REQUEST RECEIVED
2017-08-01DIVISIONAL PROCESSING COMPLETE
2017-06-30USE AMENDMENT FILED
2017-08-01STATEMENT OF USE PROCESSING COMPLETE
2017-08-17ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2017-08-18NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2017-09-19REGISTERED-PRINCIPAL REGISTER